Passing the 1000-Genome Milestone, Integrated Genomics and Tsunamic Technologies Develop High Throughput Genome Annotation System

CHICAGO, IL and Orlando, FL - December 4, 2006

Integrated Genomics (Chicago, IL) and Tsunamic Technologies (Orlando, FL) have entered into a contract to develop high-performance Linux clusters for large-scale, high throughput genome annotation and comparative genomics. 

Read More

NIH Funds Development of an Integrated Antimicrobial Target Discovery System

CHICAGO, IL and Pittsburgh, PA - October 10, 2006

Integrated Genomics Inc. (Chicago, IL), the University of Pittsburgh, and the University of Notre Dame and have been awarded a NIH grant to study bacterial pathogenic and bioterrorism agents as part of a novel research program that aims to develop and experimentally validate an integrated antimicrobial drug discovery scheme.

Read More

Chr. Hansen and Integrated Genomics to Sequence a Probiotic Lactic Acid Bacterium

CHICAGO, IL and Cambridge, MA - September 18, 2006

Integrated Genomics Inc. (Chicago, IL), a leading provider of microbial gene sequencing and analysis services, has signed an agreement with Chr. Hansen A/S in Denmark to sequence, close, and annotate the genome of a probiotic lactic acid bacterium. This contract continues a multiyear relationship between the companies in lactic acid microbial genomics.

Read More

Pathway Analysis Products by Ariadne to Feature Integrated Genomics Microbial Pathway Collection

CHICAGO, IL and Rockville, MD - May 19, 2006

Ariadne today announced that the unique Metabolic Vision microbial pathway collection developed by Integrated Genomics is now available as an ancillary pathway database for its PathwayStudio® and PathwayExpert™ software. The addition of Metabolic Vision collection expands the applications of PathwayStudio® and PathwayExpert™ to include microbial pathway analysis for basic, medical and industrial microbiology, and food and environmental research in addition to mammalian pathway analysis.

Read More

Integrated Genomics and DANONE Sign 3-Year ERGO™ License Deal

CHICAGO, IL and Palaiseau, France - March 27, 2006

The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics ERGO™ database and genomic discovery system. Scientists at the Carasso Center in France will use the ERGO™ system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.

Read More

Integrated Genomics Licenses ERGO™ Database to Chr. Hansen

CHICAGO, IL and Hoersholm, Denmark - February 7, 2006

Integrated Genomics, a leading provider of bioinformatics tools, has licensed their proprietary ERGO™ database and genomic discovery system to Chr. Hansen A/S, a global natural ingredients company. Scientists at Chr. Hansen's Genomics & Strain Development in Denmark will use the ERGO™ system to characterize and develop lactic acid bacteria used in foods and as probiotics for human health.

Read More

Integrated Genomics and GATC Renew License of ERGO™ Database to Degussa

CHICAGO, IL and Konstanz, Germany - December 4, 2005

Integrated Genomics Inc., a leading provider of bioinformatics tools, and GATC Biotech AG, have licensed Integrated Genomics' proprietary ERGO™ database and genomic discovery system to Degussa AG. Under the terms of the agreement, Scientists of Degussa's Project House ProFerm will use the ERGO™ system to optimise their production strains and find new methods of high yield production of amino acids and other specialty chemicals.

Read More

GATC Biotech and Integrated Genomics Announce Distribution Contract and Strategic Partnership

CHICAGO, IL and Konstanz, Germany - January 26, 2004

GATC Biotech AG, a leading provider of molecular biological services, and Integrated Genomics Inc. , a leading microbial genomics company, announced the closure of a multi year contract for the distribution of Integrated Genomics ERGO™ bioinformatics suite of curated microbial and eukaryotic genomes in Europe. In addition, GATC Biotech and Integrated Genomics will combine their market presentation in terms of sequencing and bioinformatics projects. Financial terms were not disclosed.

Read More

Ariadne Genomics and Integrated Genomics Announce Strategic Partnership

CHICAGO, IL and Rockville, MD - December 8, 2003

Ariadne Genomics, Inc., a leading developer of systems biology tools, today announced a strategic partnership with Integrated Genomics Inc., a leading microbial genomics company. The deal allows scientists worldwide to easily access and analyze 600+ annotated microbial and eukaryotic genomes.

Read More

Integrated Genomics, Inc. Receives AURRP Incubator of the Year Award

CHICAGO, IL - April 30, 2001

Integrated Genomics, Inc. has been recently honored with The Incubator of the Year Award by the Association of University Related Research Parks (AURRP) during their 2001 Conference held in Chicago, IL. Chairman of the Board and President, Robert Haselkorn, member of the faculty of the University of Chicago since 1961, received the award on behalf of the 130 plus employees located throughout the United States, Germany, and Russia.

Read More

Integrated Genomics and BASF Collaborate to Decipher the Genome and Metabolism of Corynebacterium glutamicum

CHICAGO, IL and Ludwigshafen, Germany - March 2, 2001

Chicago-based Integrated Genomics, Inc. and the transnational chemical company BASF Group entered into a partnership to sequence and annotate the genome of Corynebacterium glutamicum, containing more than three million DNA base pairs. With the aid of the ERGO™ bioinformatics suite, genes and functions were put into a metabolic network to give a map of how the organism converts sugar to lysine. "Now we know who the enzymatic actors are and how they interact with each other," reported Markus Pompejus, Project Manager of Lysine Research at BASF.

Read More

Integrated Genomics Signs Research and Licensing Agreement with Roche's Vitamins Division

CHICAGO, IL and Nutley, NJ - January 13, 2001

Integrated Genomics, Inc. announced today it had signed a research and licensing agreement with Roche Vitamins Inc. (RVI) to perform work in the area of microbial genomics. Under the terms of the agreement, Integrated Genomics will sequence and analyze bacterial genomes that could lead to significant improvements in Roche's ability to produce vitamins, carotenoids and fine chemicals used in foods, pharmaceuticals, cosmetics and animal feeds. RVI will also license Integrated Genomics' genome analysis suite ERGO™.

Read More

Michael Fonstein, CEO of Integrated Genomics Inc., Wins KPMG Award

CHICAGO, IL - November 20, 2000

Integrated Genomics, Inc. announced today that its CEO, Michael Fonstein, PhD, is the winner of a coveted KPMG Illinois High Tech Award. Fonstein was recognized for his significant contributions to the advancement of high technology business, having brought innovative products, services, and jobs to Illinois.

Read More